Skip to main content
HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.320
+0.016 (5.24%)
Mar 24, 2025, 9:53 AM EDT - Market open

HCW Biologics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
3.52.846.72-4.1-
Revenue Growth (YoY)
22.27%-57.73%----
Cost of Revenue
7.617.534.14---
Gross Profit
-4.12-4.692.59-4.1-
Selling, General & Admin
24.2913.448.415.32.752.08
Research & Development
7.387.599.258.077.175.28
Operating Expenses
31.6721.0317.6713.379.927.37
Operating Income
-35.79-25.72-15.08-13.37-5.82-7.37
Interest Expense
-0.38-0.28-0.13---
Interest & Investment Income
----0.020.07
Other Non Operating Income (Expenses)
0.120.740.49-0.06--
EBT Excluding Unusual Items
-36.05-25.26-14.71-13.43-5.8-7.29
Gain (Loss) on Sale of Investments
0.020.26-0.19---
Other Unusual Items
-1.3--0.57--
Pretax Income
-37.33-24.99-14.9-12.86-5.8-7.29
Net Income
-37.33-24.99-14.9-12.86-5.8-7.29
Preferred Dividends & Other Adjustments
----1.270.49
Net Income to Common
-37.33-24.99-14.9-12.86-7.07-7.78
Shares Outstanding (Basic)
3736361954
Shares Outstanding (Diluted)
3736361954
Shares Change (YoY)
3.68%0.30%90.84%296.07%10.56%-
EPS (Basic)
-1.00-0.70-0.42-0.69-1.49-1.82
EPS (Diluted)
-1.00-0.70-0.42-0.69-1.49-1.82
Free Cash Flow
-19.15-28.72-20.66-11.02-10.62-8.23
Free Cash Flow Per Share
-0.52-0.80-0.58-0.59-2.24-1.92
Gross Margin
-117.76%-165.02%38.48%-100.00%-
Operating Margin
-1023.69%-904.96%-224.32%--142.07%-
Profit Margin
-1067.83%-879.52%-221.67%--172.54%-
Free Cash Flow Margin
-547.80%-1010.51%-307.36%--258.99%-
EBITDA
-35.34-24.91-14.49-12.82-5.25-6.94
EBITDA Margin
---215.55%--128.10%-
D&A For EBITDA
0.450.810.590.540.570.42
EBIT
-35.79-25.72-15.08-13.37-5.82-7.37
EBIT Margin
---224.32%--142.07%-
Revenue as Reported
----4.1-
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q